Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Route, formulation, evidence, availability, and follow-up should be compared by a clinician rather than assumed equivalent
Recent advances in incretin-based pharmacotherapies for the treatment of obesity and diabetes
Organelle transporters and inter-organelle communication as drivers of metabolic regulation and cellular homeostasis
GLP-1 drugs have been extensively studied and are known to be effective across a wide range of patients, including those with diabetes and obesity
US$ 27.22
US$ 27.84
US$ 25.17
US$ 21.51
US$ 27.14
US$ 27.42
US$ 28.08
